EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Synthesis, Anticancer Activity, and Molecular Docking of New 1,2,3-Triazole Linked Tetrahydrocurcumin Derivatives

Meitao Duan, Ahmed Mahal iD, Anas Alkouri, Chen Wang, Zhiqiang Zhang, Jungang Ren, Ahmad J Obaidullah iD

Molecules · 25.06.2024 · 29 (13) · 3010

DOI: 10.3390/molecules29133010 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, online erschienen am 25.06.2024. Verfasst von Meitao Duan und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Xiamen Medical College, Xiamen 361023, China. Hauptthemen laut MEDLINE: Curcumin, Molecular Docking Simulation, Antineoplastic Agents, Triazoles. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science and Technology Project of Xiamen Medical college, Key Laboratory of Functional and Clinical Translational Medicine, Fujian Province University, Xiamen Medical and Health Guidance Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer is one of the deadliest diseases to humanity. There is significant progress in treating this disease, but developing some drugs that can fight this disease remains a challenge in the field of medical research. Thirteen new 1,2,3-triazole linked tetrahydrocurcumin derivatives were synthesized by click reaction, including a 1,3-dipolar cycloaddition reaction of tetrahydrocurcumin baring mono-alkyne with azides in good yields, and their in vitro anticancer activity against four cancer cell lines, including human cervical carcinoma (HeLa), human lung adenocarcinoma (A549), human hepatoma carcinoma (HepG2), and human colon carcinoma (HCT-116) were investigated using MTT(3-(4,5-dimethylthiazole-2-yl)-2,5-diphenyltetraz-olium bromide) assay. The newly synthesized compounds had their structures identified using NMR HRMS and IR techniques. Some of prepared compounds, including compounds 4g and 4k, showed potent cytotoxic activity against four cancer cell lines compared to the positive control of cisplatin and tetrahydrocurcumin. Compound 4g exhibited anticancer activity with a IC50 value of 1.09 ± 0.17 μM against human colon carcinoma HCT-116 and 45.16 ± 0.92 μM against A549 cell lines compared to the positive controls of tetrahydrocurcumin and cisplatin. Moreover, further biological examination in HCT-116 cells showed that compound 4g can arrest the cell cycle at the G1 phase. A docking study revealed that the potential mechanism by which 4g exerts its anti-colon cancer effect may be through inhabiting the binding of APC–Asef. Compound 4g can be used as a promising lead for further exploration of potential anticancer agents.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CurcuminMolecular Docking SimulationAntineoplastic AgentsTriazolesHumansCell Line, TumorDrug Screening Assays, AntitumorStructure-Activity RelationshipCell ProliferationMolecular StructureA549 CellsHCT116 CellsHep G2 Cells

Stichwörter der Autor:innen

anticancerclick reactiondrug discoverytetrahydrocurcumintriazole

Substanzen

CurcuminAntineoplastic AgentstetrahydrocurcuminTriazoles

Autor:innen und Institutionen

  • School of Pharmacy, Xiamen Medical College, Xiamen 361023, China.
  • Xiamen Medical College Research Center for Sustained and Controlled Release Formulations, Xiamen Medical College, Xiamen 361023, China.
  • Key Laboratory of Functional and Clinical Translational Medicine, Fujian Province University, Xiamen Medical College, Xiamen 361023, China.
  • Department of Medical Biochemical Analysis, College of Health Technology, Cihan University-Erbil, Erbil 44001, Kurdisan Region, Iraq.
  • College of Pharmacy, Cihan University-Erbil, Erbil 44001, Kurdisan Region, Iraq.
  • Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia.

ORCID-Profile: Ahmed Mahal, Ahmad J Obaidullah

Förderung

  • Science and Technology Project of Xiamen Medical college
  • Key Laboratory of Functional and Clinical Translational Medicine, Fujian Province University
  • Xiamen Medical and Health Guidance Project
  • Fujian Provincial Department of Education Young

Zitieren

APA

Duan, M., Mahal, A., Alkouri, A., Wang, C., Zhang, Z., Ren, J., & Obaidullah, A. J. (2024). Synthesis, Anticancer Activity, and Molecular Docking of New 1,2,3-Triazole Linked Tetrahydrocurcumin Derivatives. Molecules, 29(13), 3010. https://doi.org/10.3390/molecules29133010

Vancouver

Duan M, Mahal A, Alkouri A, Wang C, Zhang Z, Ren J, et al. Synthesis, Anticancer Activity, and Molecular Docking of New 1,2,3-Triazole Linked Tetrahydrocurcumin Derivatives. Molecules. 2024;29(13):3010. doi:10.3390/molecules29133010

BibTeX
@article{Duan2024,
  author = {Duan, Meitao and Mahal, Ahmed and Alkouri, Anas and Wang, Chen and Zhang, Zhiqiang and Ren, Jungang and Obaidullah, Ahmad J},
  title = {Synthesis, Anticancer Activity, and Molecular Docking of New 1,2,3-Triazole Linked Tetrahydrocurcumin Derivatives},
  journal = {Molecules},
  year = {2024},
  volume = {29},
  number = {13},
  pages = {3010},
  doi = {10.3390/molecules29133010}
}
Kostenlos starten →